CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)
As we mentioned in Wednesday morning’s premarket report, CURE officials conducted a Zoom webcast on the current state of the company yesterday afternoon. Today we just wanted to remind our readers that if you were unable to catch the presentation live, you can still get it on demand at the following link: https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg
CURE has a lot happening right now, so we would highly suggest getting the story straight from the horse’s mouth and hearing what company directors had to say.
_______
Direct all investor inquiries on CURR to:
Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com
Options Recaps
Our LEN and ACN idfeas from yesterday’s report panned out pretty well, and we have a couple of fresh ideas to add to the mix as well.
LEN Weekly $75.50-77 Calls
$75.50: 2.55-6.14 (+140%)
$76: 2.26-5.60 (+148%)
$76.50: 1.51-5.10 (+238%)
$77: 1.35-4.90 (+263%)
_______
ACN Weekly $255-262.50 Calls
$255: 9.99-15.00 (+50%)
$257.50: 8.19-12.30 (+50%)
$260: 5.79-10.01 (+73%)
$262.50: 4.15-9.00 (+117%)
______
Fresh Options Ideas:
WGO Weekly $60 Calls
DRI Weekly $115 Calls
Extended Watchlist:
BSRC, CEOS, SAML, TEUM, BCII, CBGH